Abpro
Pre-clinicalAbpro Holdings is a leading antibody therapy company in Boston. Our Corporation is developing antibody therapies to improve the lives of patients facing severe and life-threatening diseases.
Founded
2007
Focus
AntibodiesBiologics
About
Abpro Holdings is a leading antibody therapy company in Boston. Our Corporation is developing antibody therapies to improve the lives of patients facing severe and life-threatening diseases.
Funding History
4Total raised: $230M
PIPE$125MPerceptive AdvisorsMar 15, 2022
Series B$70MShanghai Healthcare CapitalDec 15, 2020
Series A$30MShanghai Healthcare CapitalAug 15, 2018
Seed$5MUndisclosedApr 15, 2016
Company Info
TypePrivate
Founded2007
LocationWoburn, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile